NU Hospitals, a leading nephrology and urology specialty hospital chain, has successfully raised Series A funding from Somerset Indus Capital Partners to expand its services and operational capabilities.
Information on the Target
NU Hospitals Private Limited, established in 1999 and headquartered in Bengaluru, is a prominent provider of specialized nephrology and urology services. The hospital chain operates five facilities, including two in Bengaluru, one in Shivamogga, one in Ambur, and one in Male, Maldives. NU Hospitals addresses the growing incidence of chronic kidney disease through a scalable Centre of Excellence model that focuses on delivering ethical, affordable, and clinically governed care across nephrology, urology, fertility, and renal transplant services. Their commitment extends beyond patient care, emphasizing medical education and research, alongside advanced surgical capabilities enabled by robotics. The organization upholds multiple quality accreditations, including NABH, NABL, FEQH, and ISAR, reflecting its high standards.
Industry Overview in India
The healthcare sector in India has been undergoing significant transformation, driven by rising health concerns and an increased burden of chronic diseases. Chronic kidney disease is becoming increasingly prevalent, and with a large population affected by these ailments, the demand for specialized nephrology and urology services is on the rise. The country's healthcare landscape has also seen a push towards improving access to quality and affordable healthcare, particularly in underserved regions.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Regulatory reforms and increased government focus on healthcare infrastructure have stimulated growth in the healthcare sector. Initiatives promoting private investments in healthcare facilities
Similar Deals
Tenshi Pharmaceuticals & Ashish Kacholia → Sekkei Bio
2025
Bessemer Venture Partners → Pluro Fertility and IVF
2025
Kotak Alternate Asset Managers Limited → Neuberg Diagnostics
2025
Somerset Indus Capital Partners → Cyrix Healthcare Pvt Ltd
2024
Somerset Indus Capital Partners
invested in
NU Hospitals
in 2025
in a Series A deal